Barry, OppHub America Desk · · Source: yahoo-tickers-rotation
Danaher ($DHR) INR Testing Market Projections to 2030
If point-of-care coagulation diagnostics maintain a 10.1% trajectory through 2030, watch Danaher because scalable home and clinical monitoring adoption underpins long-term device and consumable revenue streams in the healthcare sector.
Based on reporting from yahoo-tickers-rotation.
The point-of-care international normalized ratio testing market is projected to reach $2.56 billion by 2030, expanding at a 10.1% compound annual growth rate from a 2025 valuation of $1.58 billion. Danaher ($DHR+WL) is named among key industry participants scaling monitoring solutions as market expansion continues through the end of the decade.
Market context for this story
As of: Regular HoursLoading quotes…
Informational only — not investment advice. Full markets →
$DHRDanaher Corporation
TradingView
Live chart & market data via TradingView · OppHub classroom · Delayed or exchange real-time per TradingView data agreements · Not investment advice
Educational TradingView chart — search any symbol in the widget. Confirm on /markets/DHR and related $INR, $XLV. Not investment advice.
Related markets
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).
### Tape / Session Read Industry projections indicate the point-of-care international normalized ratio testing market is set to grow from $1.58 billion in 2025 to $1.75 billion in 2026, representing a compound annual growth rate of 10.4%, with forecasts pointing toward $2.56 billion by 2030 at a 10.1% CAGR. Danaher (NYSE: DHR) is highlighted alongside major sector participants as home monitoring and coagulation testing demand scales.
### Why This Lane Matters Sector-specific growth reports provide insight into medical technology capital allocation and secular demand for point-of-care diagnostics, influencing how institutional portfolio managers evaluate healthcare equipment exposure and valuation multiples.
### Money Play If point-of-care coagulation diagnostics maintain a 10.1% CAGR trajectory through 2030, watch Danaher ($DHR+WL) because scalable home and clinical monitoring adoption underpins long-term device and consumable revenue streams in the healthcare sector.
Read the full story
Original reporting and related coverage — attribution links only, not paid recommendations.
Trade this story
Robinhood
Webull
Tradier
IBKR
Chart this story
TradingView
Broker and exchange buttons use invite / refer-a-friend links (rewards may be capped). Charting links (TradingView) are partner offers that may pay OppHub America a commission at no extra cost to you.
OppSHOP
Full OppSHOP →As an Amazon Associate, OppHub America earns from qualifying purchases. Shopping here helps keep the site free — at no extra cost to you. Disclosure
OppSHOP
Related to this story
If point-of-care coagulation diagnostics maintain a 10.1% trajectory thr
Shop related →
Investing books
Read the classics
Shop this pick →
Personal finance books
Run the household books
Shop this pick →
Trading notebooks
Write the thesis first
Shop this pick →
Monitor for charts
See every pane
Shop this pick →
Story playbook
A pre-built map of what to watch — stocks, ETFs, and educational next steps. Not personalized advice.
Snapshot date: October 30, 2026 at 10:35 PM ET
This playbook was built when the story published and is not live-updated. Prices, news, and risk can change after this date — treat it as a starting map, not a current trade ticket.
Story → money map
Medical Diagnostics
A new report shows that medical testing devices used to check blood clotting are growing rapidly in popularity. Investors are watching big healthcare companies like Danaher because more people using these tests at home means steady, long-term sales for the company.
What changed
Market research projected the point-of-care international normalized ratio testing market to expand at a 10.1% CAGR through 2030.
Who wins / who loses
Medical technology companies providing point-of-care coagulation diagnostics benefit from secular demand, while traditional centralized laboratory testing providers may face decentralization headwinds.
Time horizon
Think in terms of the next few months.
Confidence & best fit
medium confidence · Long-term investor
Safer theme exposure (ETFs)
Baskets that own the theme without betting on one company.
Single stocks (higher risk)
Primary = closest to the story · Peers = same industry · Second-order = knock-on effects · Avoid = looks related but may be a trap
Primary
- $DHRWatch — track, don’t rush
Danaher makes medical testing equipment, and growing demand for easy home testing could boost their future sales.
View $DHR chart → · End-of-day delayed data
Peer
- $ABTWatch — track, don’t rush
Abbott is a major competitor in medical testing that also stands to gain from this growing health trend.
View $ABT chart → · End-of-day delayed data
- $RHHBYWatch — track, don’t rush
Roche is a giant healthcare company involved in making these blood tests.
Options (education only)
No strikes or expiries — a framework for how traders might express the view. Options can expire worthless.
Beginners should skip options for this story and stick to buying shares or ETFs if they want to invest in healthcare trends.
See options-friendly brokers →Income / OppHub America angle
Not a trade tip — ways to use the insight outside the market.
- Research local medical device supplier distributors or regional healthcare clinics adopting point-of-care testing technology.
What would break this thesis
- A significant slowdown in healthcare capital expenditure or unexpected regulatory hurdles for home-testing diagnostics could invalidate the growth thesis.
What to do next on OppHub America
Saved playbooks stay on this device for now.
Important
Not financial advice. OppHub America playbooks are educational market maps only — not recommendations to buy, sell, or hold any security. Markets move fast; information can be wrong or outdated. Trade and invest at your own risk. Do your own research or consult a licensed advisor.
Based on reporting from yahoo-tickers-rotation.
Informational and educational only — not investment, financial, or legal advice. Disclosure
Shares a vertical MP4 loop to your phone's camera roll or app share sheet (Instagram, TikTok, Facebook Reels).